SmartTRAK highlights four wound diagnostics companies utilizing artificial intelligence to watch in 2025.
Artificial intelligence (AI) is becoming increasingly ubiquitous in our personal and professional lives. AI is already being applied in healthcare in areas such as image analysis, personalized treatments and predictive care. Future potential applications include improved analysis of healthcare data, optimizing medication doses and enhancing patient education. The challenges of AI are also widely discussed, with ethical and legal concerns combined with a general worry that patient care could become dehumanized and distanced from healthcare professionals.
In this downloadable article, SmartTRAK identifies and discusses the following four diagnostic companies facilitating AI that should be watched in 2025:
- eKare
- Wound assessment company eKare has been at the forefront of the conversation around AI in wound care. The core functionality of inSight, a 3D digital wound imaging system, includes AI aspects such as ... (read more)
- Mimosa Diagnostics
- Canadian tissue oximetry company Mimosa Diagnostics primarily implements AI to enhance the usability of its Mimosa Pro device, which uses ... (read more)
- Spectral AI
- Texas-based Spectral AI has undertaken significant fundraising over recent years. Over $150 million of Biomedical Advanced Research and Development Authority (BARDA) funding since 2013 has facilitated ... (read more)
- Swift Medical
- Toronto-based Swift Medical saw a significant change in 2024. New leadership was announced in June as Dwayne Sansone and Stratos Davlos assumed the roles of CEO and CTO, respectively. The company received ... (read more)
The benefits of AI in wound care include accuracy and efficiency of wound characterization, remote monitoring, personalized care and increased accessibility to wound care ...
To find out more about how these companies are incorporating AI, just click the button below to download the complete market outlook article "Artificial Intelligence in Wound Diagnostics: Four Companies to Watch in 2025" by Kris Flinn, SmartTRAK General Manager, Wound.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
